Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Brain Functional Genome Program

Major cross-functional Brain Functional Genome Program (BFGP)

Last update: 27/12/2025 Reading time: 1min
Retour à la recherche

Deepen our understanding of the human brain during development 

The context

The BFGP program aims to tackle the following key questions:  

  • What are the molecular signatures of human brain cells across age in health and disease?
  • What are the functions of key genes in brain development, function and disease? 
The project's goals

The project's goals

The main goal of the program is to deepen our understanding of the human brain during development by linking gene expression locations to their functions, by providing to the wide community focusing in neurological and neurodegenerative diseases established, robust techniques and characterized tools.

Aim1: Atlas of the human and mouse brain molecular signature in development

We will leverage our expertise in state-of the art technologies to perform 3D visualization(iDISCO) of transcripts, combined with spatial transcriptomics on the human fetal brain, and mouse brain in development. We will develop strategies for large samples imaging, with the goal not only to develop an atlas of the human brain but also to provide a complete pipeline from protocol to analysis to the community. 


Aim2: Functional screening of disease-causing genetic variants in neurogenesis

The goal is to build an IPSC library of characterized clones. We will build a guide-RNA library for the whole genome through gene silencing (CRISPR interference). This library will serve to generate individual IPS cell lines that will be screened in 2D. More complex models, such as organoids, will be used in a later phase of the program.


Aim3: Machine learning assisted quantification of cell types 

Establish connections between the datasets (Aims 1 and 2) using ML 

News that might interest you

Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
La bibliothèque de Babel
Mental Time Travel: A New Case of Autobiographical Hypermnesia
Remembering past events in minute detail, revisiting them methodically, and reliving past emotions—this is the peculiarity of people with an exceptional memory of their own lives, known as autobiographical hypermnesia, or hyperthymesia. This...
08.28.2025 Research, science & health
Troubles du Développement Intellectuel
The "RNU-Splice" project receives support from the health sponsorship of AXA Mutuals
Intellectual development disorders (IDD) affect 2 to 3 per cent of the population and are characterized by impaired cognitive functions, impacting learning. TDI thus has an impact on coping skills with implications for daily life and is a major...
10.08.2025 Support
See all our news